
New Revision of MDCG 2020-16 Guidance on IVD Classification: Key Updates in Version 4
The Medical Device Coordination Group (MDCG) published Revision 4 of its guidance document MDCG 2020-16, titled "Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746". This updated version provides further clarification on the application of the classification rules outlined in Annex VIII of the IVDR.
As the European Authorised Representative for many IVD manufacturers, MedNet EC-REP supports its clients in understanding and implementing these regulatory updates. Below, we highlight the main changes introduced in Revision 4 and what they mean for IVD manufacturers placing products on the EU market.
What’s New in Revision 4?
The main changes in this revision concern the SARS-CoV-2 tests. They are now no longer classified in class D, but in class C in the case of self-tests and in class B in the case of tests for professional use. This is reflected in the amended examples for Rule 1 (second indent), Rule 4 and Rule 6.
With this revision, the MDCG continues its effort to improve regulatory clarity and support consistent implementation across the EU. Manufacturers are encouraged to review the updated guidance in detail and assess whether any of their products may be affected by the revised interpretation of classification rules.
Download the full Document: MDCG 2020-16 rev.4
Latest news
-250x250.jpg&w=256&q=75)
MedNet EC-REP at CMEF Shanghai 2025
We are pleased to announce that we will be exhibiting at the China International Medical Equipment Fair (CMEF) in Shanghai from April 8 to April 11, 2025.

UK Updates Post-Market Surveillance Requirements for Medical Devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has released updated guidance on post-market surveillance (PMS) requirements for medical devices in Great Britain.
-250x250.jpg&w=256&q=75)
ISO 15223-1 Amendment: EC-REP Symbol Changes to EU-REP
The International Organization for Standardization (ISO) has recently amended ISO 15223-1:2021, introducing a change from "EC-REP" to "EU-REP" for the European Authorized Representative symbol.
%20(1)-250x250.jpg&w=256&q=75)
MedNet EC-REP at MedTec Japan 2025 – Meet Us at Booth 3303
We are pleased to announce our participation as an exhibitor at MedTec Japan 2025, one of Asia’s leading trade shows for medical device design and manufacturing. The event will take place in Tokyo from April 9–11, 2025.

Swissmedic Highlights Post-Market Surveillance Obligations for Legacy Devices
Swissmedic has released findings from a recent focused action, underscoring the critical importance of robust Post-Market Surveillance (PMS) for all medical devices.

EU Publishes Second Revision of MDCG 2023-3: Key Updates for Manufacturers
The European Commission has released the second revision of the MDCG 2023-3 guidance document in January 2025. This update includes important clarifications in line with Regulation (EU) 2024/1860

EU Commission Updates Guidance on SARS-CoV-2 Test Classification
The In Vitro Diagnostic (IVD) expert panel of the European Commission has released new scientific advice regarding SARS-CoV-2.